EmERGE is a project funded by the European Union’s Horizon 2020 Research and Innovation Programme under Grant agreement no: 643736. EmERGE has developed a mHealth platform to enable self-management of HIV in patients with stable disease. The platform will build upon and integrate the existing mHealth solutions operated by pioneering healthcare providers in the UK and Spain and apply a rigorous co-design approach to ensure patient and clinician input to the solution. The EmERG

DOWNLOAD as PDF #EmERGEValidationStudy #NEWSLETTER

Brighton hospitals recruit the 100th patient in the EmERGE Validation Study Brighton has enrolled their 100th patient in the EmERGE validation study in the month of July 2017. Recruitment started in Zagreb and Brighton in April, and this rapid uptake of the new and innovative mHealth application developed byEmERGE shows that there is a clear demand for simplified and streamlined services for people living with HIV. Shorter clinic visits, easier tracking of clinical results, f

The EmERGE Validation Study is up and Running! Zagreb and Brighton enrolled their first patients to the EmERGE validation study in the month of April 2017 and we are off to a flying start. Twenty-seven patients joined the study in the first month but more, much more than this, our enrolled patients seem to love the fact that their health care might be managed their way. The purpose of the EmERGE validation study is to assess the impact of the EmERGE mHealth platform on pat

EmERGE is a project funded by the European Union’s Horizon 2020 Research and Innovation Programme under Grant agreement no: 643736. EmERGE will develop a mHealth platform to enable self-management of HIV in patients with stable disease. The platform will build upon and integrate the existing mHealth solutions operated by pioneering healthcare providers in the UK and Spain and apply a rigorous co-design approach to ensure patient and clinician input to the solution. The platfo